Heidi Cuthbert

QuickFee (ASX:QFE) reported fourth-quarter FY26 group revenue of $4.4 million, flat against normalised prior-period results.

Bernstein has increased its price target for Robinhood, pointing to the company's growing focus on tokenised assets and prediction markets.

Botala Energy (ASX:BTE) begins commercial production testing at its Pitse Pilot well 3.5B in Botswana.

MainStreet Bancshares (NASDAQ:MNSB) reported second-quarter 2026 net income of $4.7 million, driven by disciplined expense management and steady loan growth.

Dyne Therapeutics (NASDAQ:DYN) received FDA acceptance of its Biologics License Application for z-rostudirsen, an investigational treatment for Duchenne muscular dystrophy amenable to exon 51 skipping.

Boeing (NYSE:BA) and Philippine Airlines announced that the flag carrier has committed to order up to 20 Boeing 787 Dreamliner jets.

Greenwich LifeSciences (NASDAQ:GLSI) amended its Phase III breast cancer trial, expecting a 2.22x overall enrollment increase.

ING Groep (NYSE:ING) reported that Strait of Hormuz liquefied natural gas exports halted, driving regional prices up 25%.

Kraken is expanding its sports marketing strategy by building on its partnership with Tottenham Hotspur while serving as the Official Crypto Exchange Supporter of the FIFA World Cup 2026.

Ovanti (ASX:OVT) appointed former Afterpay executives to its advisory board to relaunch Buy Now, Pay Later platforms.